01.23.2024 - By American College of Cardiology
Anja Karlstaedt, MD, PhD discusses how cardiac metabolism, including SGLT2-inhibitors and GLP-1 receptor agonists, may inform cardioprotective strategies in cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.